×
About 27,292 results

ALLMedicine™ Atopic Dermatitis Center

Research & Reviews  12,447 results

The role of skin and gut microbiome and epigenetic modifications upon skin autoimmune d...
https://doi.org/10.2174/1566524020666200812222324
Current Molecular Medicine; Murdaca G, Greco M et. al.

Aug 11th, 2020 - Human microbiota and immune system are strictly connected to each other. Several studies demonstrated that normal skin and/or gut floral alterations may have negative consequences upon disease pathogenesis. Indeed, a strong association between ski...

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk A...
https://doi.org/10.1001/jamadermatol.2020.2240
JAMA Dermatology; Asgari MM, Tsai AL et. al.

Aug 11th, 2020 - Topical calcineurin inhibitors (TCIs), primarily used to treat atopic dermatitis (AD), carry a black box label warning users about the potential for increased skin cancer risk. The risk associated with keratinocyte carcinoma (KC), the most common ...

Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib...
https://doi.org/10.1007/s40257-020-00548-6
American Journal of Clinical Dermatology; Ferreira S, Guttman-Yassky E et. al.

Aug 10th, 2020 - Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities. Elevated levels of T helper (Th)2, Th22, and also some Th1 and Th17 cytokines are found in atopic dermatitis skin lesions. Similar to psoriasis,...

APRIL expression is upregulated in atopic dermatitis skin lesions and at sites of antig...
https://doi.org/10.1016/j.clim.2020.108556
Clinical Immunology (Orlando, Fla.); Leyva-Castillo JM, Jabara HH et. al.

Aug 10th, 2020 - Atopic dermatitis (AD) is the most common inflammatory skin disease. It is characterized by a defective skin barrier and a Th2 dominated skin inflammation. The TNF family member a proliferation-inducing ligand (APRIL) and its receptors transmembra...

Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
https://doi.org/10.1111/dth.14159
Dermatologic Therapy; Petra B, Petr P et. al.

Aug 10th, 2020 - Dupilumab is a monoclonal antibody against interleukin 4 (IL-4) receptor α that blocks signaling from IL-4 and IL-13, essential mediators of T helper 2 (Th2) pathway. To date, all clinical trials investigating the use of dupilumab excluded patient...

see more →

Guidelines  27 results

Atopic dermatitis/Eczema | DermNet NZ
https://www.dermnetnz.org/topics/atopic-dermatitis/

Jun 24th, 2019 - Atopic dermatitis is a chronic, itchy skin condition that is very common in children but may occur at any age. It is also known as eczema and atopic eczema and was formerly known as Besnier prurigo. It is the most common form of dermatitis. Atopi...

European task force on atopic dermatitis position paper: treatment of parental atopic d...
https://doi.org/10.1111/jdv.15709
Journal of the European Academy of Dermatology and Venereology : JEADV References; Vestergaard C, Wollenberg A et. al.

Jun 24th, 2019 - Atopic dermatitis (AD) is a common inflammatory skin disease that affects both children and adults, including a large number of adults of reproductive age. Several guidelines for the treatment of AD exist, yet specific recommendations for the trea...

Eczema - StatPearls
https://www.ncbi.nlm.nih.gov/books/NBK538209/
Nemeth,V.,et al

Jun 3rd, 2019 - Eczema, also known as atopic dermatitis, is the most common form of dermatitis. Genetic as well as environmental factors are thought to play a part in the pathogenesis. Eczema is most commonly seen in children but can be seen in adults. People ...

The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children: The Role of Maternal Dietary Restriction, Breastfeeding, Hydrolyzed Formulas, and Timing...
https://doi.org/10.1542/peds.2019-0281

Mar 17th, 2019 - This clinical report updates and replaces a 2008 clinical report from the American Academy of Pediatrics, which addressed the roles of maternal and early infant diet on the prevention of atopic disease, including atopic dermatitis, asthma, and foo...

Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) ...
https://doi.org/10.1111/jdv.14891
Journal of the European Academy of Dermatology and Venereology : JEADV; Wollenberg A, Barbarot S et. al.

Apr 20th, 2018 - This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic revi...

see more →

Drugs  597 results see all →

Clinicaltrials.gov  13,163 results

The role of skin and gut microbiome and epigenetic modifications upon skin autoimmune d...
https://doi.org/10.2174/1566524020666200812222324
Current Molecular Medicine; Murdaca G, Greco M et. al.

Aug 11th, 2020 - Human microbiota and immune system are strictly connected to each other. Several studies demonstrated that normal skin and/or gut floral alterations may have negative consequences upon disease pathogenesis. Indeed, a strong association between ski...

Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk A...
https://doi.org/10.1001/jamadermatol.2020.2240
JAMA Dermatology; Asgari MM, Tsai AL et. al.

Aug 11th, 2020 - Topical calcineurin inhibitors (TCIs), primarily used to treat atopic dermatitis (AD), carry a black box label warning users about the potential for increased skin cancer risk. The risk associated with keratinocyte carcinoma (KC), the most common ...

Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib...
https://doi.org/10.1007/s40257-020-00548-6
American Journal of Clinical Dermatology; Ferreira S, Guttman-Yassky E et. al.

Aug 10th, 2020 - Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities. Elevated levels of T helper (Th)2, Th22, and also some Th1 and Th17 cytokines are found in atopic dermatitis skin lesions. Similar to psoriasis,...

APRIL expression is upregulated in atopic dermatitis skin lesions and at sites of antig...
https://doi.org/10.1016/j.clim.2020.108556
Clinical Immunology (Orlando, Fla.); Leyva-Castillo JM, Jabara HH et. al.

Aug 10th, 2020 - Atopic dermatitis (AD) is the most common inflammatory skin disease. It is characterized by a defective skin barrier and a Th2 dominated skin inflammation. The TNF family member a proliferation-inducing ligand (APRIL) and its receptors transmembra...

Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.
https://doi.org/10.1111/dth.14159
Dermatologic Therapy; Petra B, Petr P et. al.

Aug 10th, 2020 - Dupilumab is a monoclonal antibody against interleukin 4 (IL-4) receptor α that blocks signaling from IL-4 and IL-13, essential mediators of T helper 2 (Th2) pathway. To date, all clinical trials investigating the use of dupilumab excluded patient...

see more →

News  1,031 results

Sanofi and Regeneron's Dupixent product wins Chinese approval
https://www.reuters.com/article/us-sanofi-regeneron-dupixent/sanofi-and-regenerons-dupixent-product-wins-chinese-approval-idUSKBN23Q1Y7

Jun 19th, 2020 - PARIS (Reuters) - Healthcare companies Sanofi and Regeneron said on Friday that their Dupixent product had won regulatory approval in China to treat adults suffering from moderate-to-severe atopic dermatitis, often known as eczema. “New regulation...

Sanofi and Regeneron's Dupixent shows more encouraging results
https://www.reuters.com/article/us-sanofi-regeneron-dupixent/sanofi-and-regenerons-dupixent-shows-more-encouraging-results-idUSKBN21L0K6

Apr 3rd, 2020 - PARIS (Reuters) - Healthcare companies Sanofi and Regeneron announced on Friday more encouraging results for their Dupixent product used to treat severe atopic dermatitis, often commonly known as eczema. The companies said that Dupixent Phase 3 da...

Routinely screen for depression in atopic dermatitis
https://www.mdedge.com/pediatrics/article/220092/atopic-dermatitis/routinely-screen-depression-atopic-dermatitis?channel=53
Bruce Jancin

Apr 2nd, 2020 - Screening for depression in patients with atopic dermatitis is a vital task that’s woefully neglected – and dermatologists aren’t doing any better a job of it than primary care physicians, Jonathan I. Silverberg, MD, PhD, declared in a video prese.

New topicals coming for pediatric atopic dermatitis
https://www.mdedge.com/clinicianreviews/article/219636/atopic-dermatitis/new-topicals-coming-pediatric-atopic-dermatitis?channel=53
Bruce Jancin

Mar 26th, 2020 - LAHAINA, HAWAII – Novel topical medications are in the works that will address the longstanding unmet need for a Food and Drug Administration–approved noncorticosteroid topical for use in pediatric atopic dermatitis, Lawrence F. Eichenfield, MD, r.

Colloidal Oatmeal: Optimal Skin-Directed Care for Atopic Dermatitis
https://www.mdedge.com/pediatrics/article/219464/colloidal-oatmeal-optimal-skin-directed-care-atopic-dermatitis?channel=167

Mar 23rd, 2020 - Click to read. Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that affects approximately 10% of US children.

see more →

Patient Education  27 results see all →